Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. (Q39189663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

title

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

indolent systemic mastocytosis

5 April 2020

main subject

placebo

0 references

systemic mastocytosis

1 reference

based on heuristic

inferred from title

1 reference

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Cristina Bulai Livideanu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Carle Paul

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Ewa Jassem

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Marek Niedoszytko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Srdan Verstovsek

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Patrice Dubreuil

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Olivier Hermine

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

1

Olivier Lortholary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

14

Ludovic Lhermitte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

12

Danielle Canioni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

11

Gandhi Damaj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Marie Olivia Chandesris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Gérard Guillet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Stéphane Barete

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Clive Grattan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Sylvie Fraitag

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Sophie Georgin Lavialle

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Laurent Frenzel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Lawrence B Afrin

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Katia Hanssens

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Julie Agopian

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Jean-Pierre Kinet

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Christian Auclair

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Colin Mansfield

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

Alain Moussy

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

English

0 references

publication date

7 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

volume

389

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

issue

10069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

612-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

5 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Current treatment options in patients with mastocytosis: status in 2015 and future perspectives

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Long-term treatment with imatinib results in profound mast cell deficiency in Ph chronic myeloid leukemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

The genetic basis of mast cell activation disease - looking through a glass darkly

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Comprehensive analysis of kinase inhibitor selectivity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

The tyrosine kinase network regulating mast cell activation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Mast cells and mastocytosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Case-control cohort study of patients' perceptions of disability in mastocytosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Side effects of interferon-alpha therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Diagnostic criteria and classification of mastocytosis: a consensus proposal

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Application of GEE procedures for sample size calculations in repeated measures experiments

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5985971

Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation

21 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0140-6736(16)31403-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(16)31403-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28069279 AND SRC:MED&resulttype=core&format=json

5 April 2020

PubMed publication ID

28069279

1 reference